A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07171164
Status
Recruiting
Apply to this trial

Conditions

  • Older Adults Without Any Specific Clinical Condition
  • RSV Immunization
  • Social Networks
  • Vaccine Uptake

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Motivate Aim: CHW text message reminders and counseling — BEHAVIORAL
    Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage RSV vaccine uptake.
  • Motivate Aim: CHW text message reminders only — BEHAVIORAL
    Participants receive text message reminders along with information about RSV and the RSV vaccine to encourage vaccine uptake, but do not receive the counseling intervention
  • Activate Aim: CHW text message reminders and counseling — BEHAVIORAL
    Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage discussion of RSV vaccine uptake among older adults in their social networks
  • Activate Aim: CHW text message reminders only — BEHAVIORAL
    Participants receive text message reminders along with information about RSV and the vaccine to encourage discussion of RSV vaccine uptake among older adults in their social networks, but do not receive the counseling intervention

Study Details

In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2) encourage younger adults to discuss RSV vaccination with their older friends and family members (Activate phase).

Key Dates

Start date
Sep 10, 2025
Status verified
Sep 2025
Primary completion
Nov 30, 2028
Completion
Nov 30, 2028

Study Design

Enrollment
750 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Motivate Aim: CHW text message reminders and counseling
  • Active Comparator: Motivate Aim: CHW text message reminders only
  • Experimental: Activate Aim: CHW text message reminders and counseling
  • Active Comparator: Activate Aim: CHW text message reminders only

Primary Outcome Measure

Motivate Aim Primary Outcome - RSV Vaccine Uptake [ Time Frame: 60 days from study enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94110
RSV Uptake Study Coordinator
[email protected]
415-608-8339

Find similar trials in San Francisco, CA

By research site
University of California, San Francisco· San Francisco, CA

Related Studies